Autopsy report · NCT00790101
Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation
Cause of deathNo reason given
Life of this trial
- Registered 4 years 5 months after it had already started.
- Ran for about 4 months before it stopped.
- 6 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Sanofi
- Sponsor type
- Industry
- Conditions
- Osteoporosis, Postmenopausal
- Interventions
- Risedronate; Raloxifene; Placebo
- Participants
- 6
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.